P. Chérubin

Paliperidone palmitate versus oral antipsychotics in recently diagnosed schizophrenia

A. Schreiner, Kaire Aadamsoo, A.C. Altamura et al. · Schizophrenia Research · 2015 · 143 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17

Intramuscular long-acting paliperidone palmitate in acute patients with schizophrenia unsuccessfully treated with oral antipsychotics

L. Hargarter, P. Chérubin, Paul Bergmans et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2014 · 58 citations · Full text

Medicine, Pharmacology, Psychiatry +17

A Prospective Flexible-Dose Study of Paliperidone Palmitate in Nonacute But Symptomatic Patients With Schizophrenia Previously Unsuccessfully Treated With Oral Antipsychotic Agents

A. Schreiner, Paul Bergmans, P. Chérubin et al. · Clinical Therapeutics · 2014 · 39 citations · Full text

Medicine, Pharmacology, Psychiatry +15

Once-monthly paliperidone palmitate in recently diagnosed and chronic non-acute patients with schizophrenia

L. Hargarter, Paul Bergmans, P. Chérubin et al. · Expert Opinion on Pharmacotherapy · 2016 · 33 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Long-acting injectable risperidone and oral antipsychotics in patients with schizophrenia: results from a prospective, 1-year, non-interventional study (InORS)

A. Schreiner, Anders Svensson, Robert Wapenaar et al. · The World Journal of Biological Psychiatry · 2014 · 20 citations

Pharmacy, Pharmacotherapy, Psychiatry +17